237 results
Page 8 of 12
20-F/A
EX-4.39
8n7kw8sf22i8 n1v2a
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.38
d3v1d 4dc
23 Mar 15
Annual report (foreign) (amended)
12:00am
6-K
EX-99
tpembk1l
6 Mar 15
BioLineRx Prices $25 Million Underwritten Public Offering
12:00am
424B5
d52x13ezp3oq5ada0z
6 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
r8zc9w0 2dl9
5 Mar 15
Current report (foreign)
12:00am
424B5
sgb71
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
wsshxc17 vt71mg
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
a8q2s5kt
2 Mar 15
Current report (foreign)
12:00am
6-K
EX-99.1
lucg41kyg7
14 Jan 15
BioLineRx Announces Completion of Enrollment in CE
12:00am
6-K
EX-99
pnkdx1 xyo4f
6 Jan 15
BioLineRx Completes Dose Escalation Stage of
12:00am
6-K
EX-99
0q5lqd1
23 Dec 14
Current report (foreign)
12:00am
6-K
EX-99
c58yn pgt2earv1
16 Dec 14
Current report (foreign)
12:00am
6-K
EX-99
dw57 9lxemxtl6
12 Dec 14
BioLineRx Presents Multi-Year Clinical Development
12:00am
6-K
EX-99
6nbg ecl8rpq
8 Dec 14
BioLineRx Reports Positive Data from Ongoing Phase 2a
12:00am
6-K
EX-99
ycdphf5innz8l76 e7nz
10 Nov 14
BioLineRx Reports Third Quarter 2014 Financial Results
12:00am
6-K
EX-99
dnfou0yaefugzio
5 Nov 14
BioLineRx Announces Successful Final Results of
12:00am
6-K
EX-99
2prtw0o8 xi
3 Nov 14
Current report (foreign)
12:00am
6-K
EX-99
gsn8 po8k
31 Oct 14
BioLineRx Reports Publication in Peer Review Journal of
12:00am